Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018

Clinical trial NCT00945490 · COMPLETED

Trial details

NCT number: NCT00945490
Sponsor: Nymox Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)

Start date: 2009-05-01
Primary completion: 2014-05-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.